Influence of accelerated storage conditions on the stability of vancomycin-loaded poly(D,L-lactide-co-glycolide) microspheres

Fabad Journal of Pharmaceutical Sciences

Volumn 29, Issue 3, 2004, Pages 111-116

  Sayin, Burcu ^a   Çaliş, Sema ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Accelerated conditions; Humidity; Microspheres; PLGA; Stability; Temperature

Indexed keywords

MICROSPHERE; POLYGLACTIN; VANCOMYCIN;

ARTICLE; DRUG STABILITY; DRUG STORAGE; EMULSION; HUMIDITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; TEMPERATURE SENSITIVITY;

EID: 33744471937     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices, Biomaterials, 23, 1649-1656, 2002.
2. Blanco-Prieto MJ, Besseghir K, Zerbe O, Andris D, et al. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres, J. Control. Rel., 67, 19-28, 2000.
3. Johansen P, Men Y, Merkle HP, Gander B. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination, Eur. J. Pharm. Biopharm., 50, 129-146, 2000.
4. Jain RA, Rhodes CT, Railkar AM, Malick AW, et al. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables, Eur. J. Pharm. Biopharm., 50, 257-262, 2000.
5. Wu XS. Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise Encyclopedic Handbook of Biomaterials and Bioengineering, Marcel Dekker, New York, 1015-1054, 1995.
6. Göpferich A. Polymer degradation and erosion: mechanism and applications, Eur. J. Pharm. Biopharm., 42, 1-11, 1996.
7. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475-2490, 2000.
8. Loo SCJ, Ooi CP, Wee SHE, Boey YCF. Effect of isothermal annealing on the hydrolytic degradation rate of poly(lactide-co-glycolide) (PLGA), Biomaterials, 26(16), 2827-2833, 2005.
9. Aso Y, Yoshiyoka S, Wan Po L, Terao T. Effect of temperature on mechanisms of drug release and matrix degradation of poly(D,L-lactide) microspheres, J. Control. Rel., 31, 33-39, 1994.
10. Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers, Chasin M, Langer R (eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1-41, 1990.
11. Hincal AA, Çaliş S. Microsphere preparation by solvent evaporation method, Wise DL (eds.), Handbook of Pharmaceutical Controlled Release Technology, Marcel Dekker, New York, 329-343, 2000.
12. Yenice İ, Çaliş S, Atilla B, et al. In vitro in vivo evaluation of the efficiency of teicoplanin loaded biodegradable microparticles formulated for implantation to infected bone defects, J. Microencapsulation, 20(6), 705-717, 2003.
13. Shah S, Cha Y, Pitt C. Poly(glycolic acid-co-lactic acid): diffusion or degradation controlled drug delivery?, J. Control Release, 18, 261-270, 1992.
14. Makino K, Ohshima H, Kondo T. Mechanism of hydrolytic degradation of poly(-lactide) microcapsules: effect of pH, ionic strength and buffer concentration, J. Microencapsul. 3, 203-212, 1986.
15. Grizzi H, Garreau S, Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 16, 305-311, 1995.
16. Dunne M, Corrigan OI, Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, 21, 1659-1668, 2000.
17. Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers, Eur. J. Pharm. Sci., 8, 99-107, 1999.
18. von Burkersrodaa F, Schedlb L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion, Biomaterials, 23(21), 4221-4231, 2002.
19. Khidr SH, Niazy EM, El-Sayed YM. Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres, J. Microencapsulation, 12(6), 651-660, 1995.
20. O'Donnell PB, McGinity JW. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride, Eur. J. Pharm. Biopharm., 45, 83-94, 1998.
21. Lewis L, Boni RL, Adeyeye CM. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres, J. Microencapsulation., 15(5), 555-567, 1998.
22. Delgado A, Evora C, Llabres M. Effect of storage on the stability of DL-PLA microspheres containing methadone, Int. J. Pharm., 166, 223-225, 1998.
23. Martindale: the extra pharmacopeia, 33rd ed., Reynolds EFJ (eds), The Pharmaceutical Press, 267-269, 2002.
24. Gupta VD, Stewart KR, Nohria S. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections, Am. J. Hosp. Pharm., 43, 1729-1731, 1986.
25. Walker SE, Birkhans B. Stability of intravenous vancomycin. The Canadian Journal of Hospital Pharmacy, 41(5), 233-238, 1988.
26. Trissel LA. Trissel's Stability of Compounded Formulations, Washington, American Pharmaceutical Association, 260-263, 1996.